GlassScriptPhysician profile
Edward Makler
NPI 1598850133
$4,185.12
in general payments reported to CMS, 2019-2025
18 companies · $974 in 2025
The $974 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $119 · 2021: $127 · 2022: $234 · 2023: $1,545 · 2024: $690 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,682 · Travel and Lodging: $434 · Entertainment: $92.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.78 |
| Travel and Lodging | $434.36 |
| Entertainment | $92.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,477.16 | 2023-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $576.12 | 2022-2025 | Infuse, Multi-Focal, Xiidra |
| Glaukos Corporation | $265.82 | 2019-2025 | |
| Genzyme Corporation | $243.30 | 2019 | |
| Lkc Technologies, INC. | $232.81 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $221.48 | 2020-2025 | |
| Oyster Point Pharma, INC. | $204.43 | 2023 | Tyrvaya |
| Dompe US, INC. | $200.23 | 2025 | Oxervate |
| Harrow Eye, LLC | $120.40 | 2024 | Vevye |
| Novartis Pharmaceuticals Corporation | $118.77 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $108.83 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.26 | 2021 | |
| Biotissue Holdings INC. | $108.20 | 2024 | |
| Optos, INC. | $92.81 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Maculogix, INC. | $36.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $31.95 | 2023-2024 | Tearlab Osmolarity System, Scoutpro Osmolarity System |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $18.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Makler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.